未登录 分享 收藏
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-study Ethier, J. L.; Ocana, A.; Rodriguez Lescure, A.; Ruiz, A.; Alba, E.; Calvo, L.; Ruiz-Borrego, M.; Santaballa, A.; Rodriguez, C. A.; Crespo, C.; Ramos, M.; Gracia Marco, J.; Lluch, A.; Alvarez, I.; Casas, M.; Sanchez-Arago, M.; Carrasco, E.; Caballero, R.; Amir, E.; Martin, M. 分享 收藏
分享 收藏
Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: Results from a 2-year multicentre observational study (ZOMAR study) Barnadas, Agusti; Manso, Luis; de la Piedra, Concepcion; Meseguer, Cristina; Crespo, Carmen; Gomez, Patricia; Calvo, Lourdes; Martinez, Purificacion; Ruiz-Borrego, Manuel; Perello, Antonia; Anton, Antonio; Codes, Manuel; Margeli, Mireia; Murias, Adolfo; Salvador, Javier; Angel Segui, Miguel; de Juan, Ana; Gavila, Joaquin; Luque, Maria; Perez, Diego; Zamora, Pilar; Arizcuma, Alberto; Ignacio Chacon, Jose; Heras, Lucia; Martin-Fernandez, Marta; Mahillo-Fernandez, Ignacio; Tusquets, Ignacio 分享 收藏
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2-breast cancer patients: results from the GEICAM 9906 trial Martin, Miguel; Brase, Jan C.; Calvo, Lourdes; Krappmann, Kristin; Ruiz-Borrego, Manuel; Fisch, Karin; Ruiz, Amparo; Weber, Karsten E.; Munarriz, Blanca; Petry, Christoph; Rodriguez, Cesar A.; Kronenwett, Ralf; Crespo, Carmen; Alba, Emilio; Carrasco, Eva; Casas, Maribel; Caballero, Rosalia; Rodriguez-Lescure, Alvaro 分享 收藏
Prognostic performance of the EndoPredict score in node-positive chemotherapy-treated ER+/HER2-breast cancer patients: results from the GEICAM/9906 trial. Martin, M.; Brase, J. C.; Ruiz-Borrego, M.; Krappmann, K.; Munarriz, B.; Fisch, K.; Ruiz, A.; Weber, K. E.; Crespo, C.; Petry, C.; Rodriguez, C. A.; Kronenwett, R.; Calvo, L.; Alba, E.; Carrasco, E.; Casas, M.; Caballero, R.; Rodriguez-Lescure, A. 分享 收藏
Phase Ill trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer First efficacy results from the LEA study. Martin, M.; Loibl, S.; von Minckwitz, G.; Morales, S.; Crespo, C.; Anton, A.; Guerrero, A.; Aktas, B.; Schoenegg, W.; Munoz, M.; Garcia-Saenz, J. A.; Gil, M.; Ramos, M.; Carrasco, E.; Liedtke, C.; Wachsmann, G.; Mehta, K.; De la Haba, J. R. 分享 收藏
Association between Circulating Tumor Cells and Bone Turnover Markers in patients with breast cancer and bone metastases on treatment with bisphosphonates (ZOMAR study) Manso, L.; Barnadas, A.; Tusquets, I.; Crespo, C.; Gomez, P.; Calvo, L.; Ruiz, M.; Martinez, P.; Perello, A.; Anton, A.; Codes, M.; Margeli, M.; Murias, A.; Salvador, J.; Segui, M. A.; De Juan, A.; Gavila, J.; Luque, M.; Perez, D.; Zamora, P.; Arizcum, A.; Chacon, J. I.; Heras, L.; De la Piedra, C. 分享 收藏
Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy as First-Line Treatment for Advanced Breast Cancer: The LEA Study. De la Haba-Rodriguez, J. R.; von Minckwitz, G.; Martin, M.; Morales, S.; Crespo, C.; Guerrero, A.; Anton-Torres, A.; Gil, M.; Munoz, M.; Carrasco, E.; Rodriguez-Martin, C.; Porras, I.; Aktas, B.; Schoenegg, W.; Tio, J.; Mehta, K.; Loibl, S. 分享 收藏
PAM50 Proliferation Index Predicts Response to Weekly Adjuvant Paclitaxel in Node -Positive Operable Breast Cancer. Martin, M.; Rodriguez-Lescure, A.; Stijleman, I. J.; Munarriz, B.; Ruiz-Borrego, M.; Davis, C.; Crespo, C.; Rodriguez, C. A.; Ebbert, M. T. W.; Alvarez, I.; Furio, V.; Bastien, R. R. L.; Garcia, A. M.; Cheang, M. C.; Palacios, J.; Ellis, M. J. C.; Carrasco, E.; Casas, M. I.; Caballero, R.; Perou, C. M.; Bernard, P. S. 分享 收藏
Prospective Observational Study To Describe the Clinicopathological and Biological Characteristics and the Management of Metastatic Breast Cancer Patients Who Experienced Complete or Partial Remission or Disease Stabilization during at Least 3 Years. Zamora, P.; Perez-Carrion, R.; Manso, L.; Crespo, C.; Mendiola, C.; Alvarez-Lopez, I.; Margeli, M.; Bayo-Calero, J. L.; Gonzalez-Farre, X.; Santaballa, A.; Ciruelos, E. M.; Afonso, R.; Lao, J.; Catalan, G.; Alvarez-Gallego, J. V.; Miramon-Lopez, J.; Salvador-Bofill, F. J.; Ruiz-Borrego, M. 分享 收藏
Association Between Circulating Tumour Cells and Bone Turnover Markers in Patients With Breast Cancer and Bone Metastases on Treatment With Bisphosphonates (ZOMAR Study) Manso, L.; Tusquets, I.; De la Piedra, C.; Crespo, C.; Gomez, P.; Calvo, L.; Galve, E.; Ruiz Borrego, M.; Rifa, J.; Barnadas, A. 分享 收藏
Intermediate study: Observational study about levels of biochemical markers of bone turnover in patients with breast cancer and bone metastases (ZOMAR study) De La Piedra, C.; Tusquets, I.; Gomez, P.; Crespo, C.; Calvo, L.; Manso, L.; Martinez, P.; Ruiz-Borrego, M.; Murias, A.; Barnadas, A. 分享 收藏
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer Martin, Miguel; Rodriguez-Lescure, Alvaro; Ruiz, Amparo; Alba, Emilio; Calvo, Lourdes; Ruiz-Borrego, Manuel; Santaballa, Ana; Rodriguez, Cesar A.; Crespo, Carmen; Abad, Mar; Dominguez, Severina; Florian, Jesus; Llorca, Cristina; Mendez, Miguel; Godes, Maria; Cubedo, Ricardo; Murias, Adolfo; Batista, Norberto; Jose Garcia, Maria; Caballero, Rosalia; de Alava, Enrique 分享 收藏
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer Martin, Miguel; Rodriguez-Lescure, Alvaro; Ruiz, Amparo; Alba, Emilio; Calvo, Lourdes; Ruiz-Borrego, Manuel; Munarriz, Blanca; Rodriguez, Cesar A.; Crespo, Carmen; de Alava, Enrique; Lopez Garcia-Asenjo, Jose Antonio; Dolores Guitian, Maria; Almenar, Sergio; Fernando Gonzalez-Palacios, Jesus; Vera, Francisco; Palacios, Jose; Ramos, Manuel; Gracia Marco, Jose Manuel; Lluch, Ana; Alvarez, Isabel; Angel Segui, Miguel; Ignacio Mayordomo, Jose; Anton, Antonio; Manuel Baena, Jose; Plazaola, Arrate; Modolell, Alfonso; Pelegri, Amadeu; Ramon Mel, Jose; Aranda, Enrique; Adrover, Encarna; Valero Alvarez, Jose; Garcia Puche, Jose Luis; Sanchez-Rovira, Pedro; Gonzalez, Sonia; Manuel Lopez-Vega, Jose 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
